Insider Transactions in Q2 2022 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Mark S Shearman EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
5,145
-7.0%
|
$51,450
$10.06 P/Share
|
|
Jun 03
2022
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,527
-1.81%
|
$16,797
$11.54 P/Share
|
|
Jun 03
2022
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
1,123
-1.69%
|
$12,353
$11.54 P/Share
|
|
Jun 02
2022
|
Gilmore Neil O'Neill CEO |
BUY
Grant, award, or other acquisition
|
Direct |
86,655
+50.0%
|
-
|
|
May 09
2022
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
297
-0.44%
|
$3,861
$13.11 P/Share
|
|
Apr 01
2022
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
1,258
-1.85%
|
$23,902
$19.64 P/Share
|